Telogen Effluvium: Causes, Timeline, and Evidence-Based Treatment

What Is Telogen Effluvium?

Telogen effluvium is a diffuse, non-scarring hair loss condition in which a disproportionate number of hair follicles prematurely enter the telogen (resting) phase of the growth cycle. The result is noticeable, often alarming, shedding that begins weeks to months after a physiologic stressor. TE is the second most common cause of hair loss seen by dermatologists, after androgenetic alopecia [1].

The Normal Hair Growth Cycle

Each scalp follicle cycles independently through three phases: anagen (active growth, 2 to 6 years), catagen (transitional regression, 2 to 3 weeks), and telogen (rest, approximately 3 months). At any given time, roughly 85 to 90% of scalp hairs are in anagen and 10 to 15% are in telogen [2]. In TE, a systemic trigger synchronizes a large cohort of anagen follicles into telogen simultaneously, so they all shed together about 3 months later.

Acute vs. Chronic TE

Acute TE lasts fewer than 6 months and resolves once the trigger is gone. Chronic TE (CTE), first described by Whiting in 1996, persists beyond 6 months and can fluctuate for years [3]. CTE disproportionately affects women aged 30 to 60. It does not progress to permanent baldness, but the prolonged shedding causes significant distress.

Common Causes and Triggers

The defining feature of TE is that it is always reactive. Something pushes follicles out of anagen. Identifying that something is the entire treatment strategy.

Physiologic and Hormonal Triggers

Postpartum shedding is the most recognized form of TE. During pregnancy, elevated estrogen prolongs anagen, producing thicker-looking hair. After delivery, estrogen drops sharply and the retained hairs enter telogen en masse, shedding at 2 to 4 months postpartum [4]. A similar mechanism occurs after discontinuing oral contraceptives.

Thyroid dysfunction, both hypo- and hyperthyroidism, slows follicular cycling and can trigger TE. The American Thyroid Association recommends TSH screening in any patient presenting with new diffuse hair loss [5].

Nutritional Deficiencies

Iron deficiency, even without frank anemia, is one of the most common correctable causes. A 2006 study in the Journal of the American Academy of Dermatology found that women with TE had significantly lower mean serum ferritin levels (31.3 ng/mL) compared to controls (59.5 ng/mL) [6]. Most trichologists target a ferritin level above 40 ng/mL for optimal hair growth, though some experts recommend above 70 ng/mL.

Severe caloric restriction, crash dieting, and protein deficiency also trigger TE. Zinc and vitamin D deficiency have each been associated with diffuse shedding in smaller observational studies [7].

Medications and Medical Events

High fever, major surgery, severe infection (including COVID-19), and significant psychological stress can all precipitate TE. A retrospective study published in The Lancet found that approximately 25% of hospitalized COVID-19 patients reported hair shedding within 3 to 6 months of infection [8].

Drug-induced TE has been documented with retinoids (including isotretinoin), beta-blockers, anticoagulants (especially heparin), anticonvulsants, and excess vitamin A supplementation. The onset follows the same 2 to 3 month latency.

How Telogen Effluvium Is Diagnosed

TE is a clinical diagnosis. No single lab test confirms it. The diagnostic process relies on a careful history and a few simple bedside maneuvers.

History and Hair-Pull Test

A dermatologist will ask about events occurring 2 to 4 months before shedding onset: surgery, illness, dietary changes, new medications, childbirth, emotional trauma. A positive hair-pull test (more than 10% of 60 grasped hairs come out as telogen club hairs) supports the diagnosis [9].

Trichoscopy and Biopsy

Dermoscopic examination (trichoscopy) in TE shows short regrowing hairs of uniform diameter, empty follicular ostia, and an absence of the miniaturized follicles seen in androgenetic alopecia. Scalp biopsy is reserved for ambiguous cases. When performed, it reveals a telogen-to-anagen ratio exceeding 25%, compared to the normal 10 to 15% [10].

Laboratory Workup

A targeted lab panel helps rule out correctable causes: CBC, serum ferritin, TSH, free T4, vitamin D (25-OH), zinc, and a comprehensive metabolic panel. In women, adding DHEA-S and total testosterone helps distinguish TE from early female pattern hair loss.

Telogen Effluvium vs. Other Types of Hair Loss

Patients often confuse TE with other conditions. Distinguishing between them shapes both treatment and prognosis.

TE vs. Androgenetic Alopecia (Pattern Hair Loss)

Androgenetic alopecia (AGA) is driven by dihydrotestosterone (DHT) sensitivity in genetically susceptible follicles. In men, it creates the classic receding hairline and vertex thinning. In women, it presents as diffuse thinning over the crown with preservation of the frontal hairline, classified by the Ludwig scale [11].

The key differences: AGA is gradual (months to years), patterned, and progressive without treatment. TE is abrupt (weeks), diffuse across the entire scalp, and self-limited. AGA shows follicular miniaturization on trichoscopy. TE does not. Both conditions can coexist, and TE can unmask previously unnoticed early AGA.

TE vs. Alopecia Areata

Alopecia areata (AA) is an autoimmune condition in which T-lymphocytes attack the hair bulb, producing discrete, well-circumscribed round patches of complete hair loss. Exclamation-point hairs (short, broken hairs that taper toward the scalp) are pathognomonic [12]. AA affects roughly 2% of the global population and can occur at any age. TE produces diffuse thinning, not patches, and lacks exclamation-point hairs.

TE and Acne Vulgaris: An Overlooked Connection

Acne vulgaris treatments, particularly isotretinoin (Accutane) and spironolactone, can interact with hair cycling. Isotretinoin-induced TE occurs in an estimated 3 to 6% of patients, typically at doses above 0.5 mg/kg/day [13]. The shedding usually reverses within 2 to 4 months of completing the course. Spironolactone, conversely, is sometimes used off-label for both hormonal acne and female pattern hair loss because it blocks androgen receptors.

Treatment: Correcting the Trigger Comes First

There is no FDA-approved medication specifically for telogen effluvium. Treatment centers on identifying and removing the trigger, then supporting the follicular environment for regrowth.

Nutritional Repletion

If serum ferritin is below 40 ng/mL, oral iron supplementation (ferrous sulfate 325 mg daily or ferrous bisglycinate 25 mg for better tolerability) should continue until ferritin exceeds 50 ng/mL. A randomized controlled trial of 80 women with chronic TE and low ferritin showed a 39% increase in hair density after 6 months of iron repletion compared to 5% in the placebo group [14].

Correct vitamin D if 25-OH levels fall below 30 ng/mL. Ensure adequate protein intake (at minimum 0.8 g/kg/day, though 1.2 g/kg/day is preferred during recovery). Biotin supplementation is widely marketed but lacks strong evidence for TE specifically; it may help in documented biotin deficiency, which is rare.

Thyroid Optimization

If TSH is outside the reference range, thyroid hormone replacement or antithyroid therapy should be initiated. Hair regrowth typically begins 4 to 6 months after thyroid levels normalize.

Topical Minoxidil

While not treating the root cause, topical minoxidil 5% can shorten the telogen phase and promote earlier anagen re-entry. A 2004 study by Olsen et al. Demonstrated that minoxidil 5% solution applied twice daily increased non-vellus hair count by 18.6 hairs/cm² at 48 weeks in women with diffuse hair loss [15]. It is used off-label in TE when shedding is prolonged or distressing.

What Not to Do

PRP (platelet-rich plasma) injections lack controlled trial data for TE specifically, though preliminary evidence exists for AGA. Avoid adding multiple unproven supplements simultaneously, as this makes it impossible to identify what is working. Do not start finasteride for TE alone; finasteride blocks 5-alpha reductase and is indicated for AGA in men, not for the follicular-cycling disruption of TE.

Timeline: When Does Hair Grow Back?

Acute TE follows a predictable arc. Shedding typically peaks at 3 to 4 months after the trigger and slows between months 4 and 6. New growth appears as short, fine hairs of normal caliber. Full cosmetic recovery takes 6 to 12 months from the point shedding stops.

Factors That Delay Recovery

Ongoing nutritional deficits, uncontrolled thyroid disease, chronic psychological stress, or continued use of a culprit medication will prolong shedding indefinitely. Chronic TE is diagnosed when shedding persists beyond 6 months without a single identifiable ongoing trigger.

Monitoring Progress

Serial photography (global scalp photos monthly) is more reliable than subjective shedding counts. The daily hair-shed count (collecting all shed hairs for 3 consecutive days) provides a rough quantitative measure. Counts above 100 hairs/day suggest active TE; counts below 60 suggest resolution.

"The most important thing I tell patients with telogen effluvium is that this is a self-limited condition. The hair follicle is not destroyed, it is resting. Once we fix what pushed it into rest, regrowth is expected," says Dr. Wilma Bergfeld, former president of the American Academy of Dermatology and senior dermatologist at Cleveland Clinic [16].

When to See a Specialist

Not every episode of increased shedding requires a dermatologist, but certain scenarios warrant evaluation.

Red Flags

Shedding lasting more than 6 months, focal patches of baldness (suggesting alopecia areata), progressive widening of the part line (suggesting AGA), or associated symptoms like fatigue, weight changes, or menstrual irregularity (suggesting systemic disease) all merit specialist referral.

The Role of a Trichologist

Board-certified dermatologists with trichology training can perform scalp biopsy, advanced trichoscopy, and hair-cycle analysis (phototrichogram). They also manage cases where TE overlaps with AGA, a common scenario in women over 40 that requires dual-targeted treatment.

Lifestyle Strategies That Support Recovery

While correcting the medical trigger is primary, several evidence-informed habits can support follicular health during recovery.

Stress Reduction

A 2021 study in Nature demonstrated that chronic stress hormones (corticosterone in mice, cortisol in humans) directly suppress dermal papilla signaling and prolong the telogen phase [17]. Stress management through cognitive behavioral therapy, regular exercise, or mindfulness practices may accelerate anagen re-entry, though human clinical trials quantifying this effect are limited.

Gentle Hair Care

Avoid tight hairstyles (which add traction alopecia to TE), excessive heat styling, and harsh chemical treatments during active shedding. Use a wide-tooth comb on wet hair. These measures do not treat TE but prevent additional mechanical hair loss from compounding the problem.

Diet

A Mediterranean-style diet rich in omega-3 fatty acids, leafy greens, legumes, eggs, and lean protein provides the amino acids (especially L-lysine and L-cysteine) and micronutrients (iron, zinc, selenium) that support keratin synthesis. A 2018 study in Dermatology and Therapy found adherence to a Mediterranean diet was associated with a lower risk of AGA progression, though similar data for TE is lacking [18].

Emerging Research

Investigational approaches include low-level laser therapy (LLLT), JAK inhibitors (currently approved only for alopecia areata; tofacitinib received FDA approval for severe AA in 2022), and microbiome-based interventions targeting scalp inflammation. None of these have completed phase III trials for TE. The most promising near-term advance is standardized trichoscopic AI analysis for earlier, more objective differentiation between TE and early AGA.

"We are entering an era where digital trichoscopy paired with machine learning can quantify the telogen ratio in under 60 seconds, removing much of the subjectivity from diagnosis," notes Dr. Antonella Tosti, Professor of Dermatology at the University of Miami Miller School of Medicine [19].

Patients with suspected TE should have serum ferritin, TSH, and 25-OH vitamin D measured at baseline and repeated at 3 months; if all values are within target and shedding has not improved by 6 months, scalp biopsy should be performed to exclude early androgenetic alopecia or other mimics [10].